IPSEN: Disclosure Transaction in Own Shares Between 13/06/2022 and 17/06/2022

Business Wire · 21.06.2022, 18:00 Uhr

Artikel teilen:

Regulatory News:

IPSEN:

Aggregated presentation by day and market

Issuer name	Issuer identification code	Transaction date	Identification code of the financial instrument	Daily total volume (in number of shares)	Daily weighted average price of shares acquired	Platform
IPSEN	549300M6SGDPB4Z94P11	13/06/2022	FR0010259150	7,500	86.2925	XPAR
IPSEN	549300M6SGDPB4Z94P11	14/06/2022	FR0010259150	5,433	84.7013	XPAR
IPSEN	549300M6SGDPB4Z94P11	15/06/2022	FR0010259150	2,500	84.1820	XPAR
IPSEN	549300M6SGDPB4Z94P11	16/06/2022	FR0010259150	7,000	81.6339	XPAR
IPSEN	549300M6SGDPB4Z94P11	17/06/2022	FR0010259150	4,957	81.2863	XPAR
			TOTAL	27,390	83.6876

Craig Marks
Vice-President Investor Relations
Tel.: +44 (0) 7584 349 193
E-mail: craig.marks@ipsen.com

Fabien Puibarreau
Head of Company Law and Securities Law
Tel.: +33 (0)1 58 33 58 86
E-mail: fabien.puibarreau@ipsen.com

Einstellungen	Aktueller Kurs	Perf. akt. Perf. 1 Jahr	Chart 1 Jahr	Einstellungen
Ipsen	–	–

"FT": Abnehm-Spezialist Metsera im Fokus

gnubreW

gestern, 10:18 Uhr · UniCredit

Studiendaten stützen

Schweizer Pharmakonzern